---
title: Proposals for Revised International Working Group-European LeukemiaNet Criteria
  for Anemia Response in Myelofibrosis
date: '2024-08-08'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39116296/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240809181135&v=2.18.0.post9+e462414
source: Blood
description: With emerging new drugs in myelofibrosis (MF), a robust and harmonized
  framework for defining the severity of anemia and response to treatment will enhance
  clinical investigation and facilitate inter-study comparisons. Accordingly, the
  lead authors on the 2013 edition of the International Working Group-European LeukemiaNet
  (IWG-ELN) response criteria in MF were summoned to revise their document with the
  intent to i) account for gender-specific differences in determining hemoglobin levels
  ...
disable_comments: true
---
With emerging new drugs in myelofibrosis (MF), a robust and harmonized framework for defining the severity of anemia and response to treatment will enhance clinical investigation and facilitate inter-study comparisons. Accordingly, the lead authors on the 2013 edition of the International Working Group-European LeukemiaNet (IWG-ELN) response criteria in MF were summoned to revise their document with the intent to i) account for gender-specific differences in determining hemoglobin levels ...